Doctor Anywhere, a Singaporean company that aims to make healthcare services accessible for the masses through the integration of online and offline channels, has secured SGD88 million US$65.7 million) Series C financing round, led by local growth equity investor Asia Partners. 

Novo Holdings (Denmark), Philips, and OSK-SBI Venture Partners (Malaysia), besides existing investors EDBI, Square Peg, IHH Healthcare, Kamet Capital, and Pavilion Capital, also joined the round. 

This round brings the total capital raised by Doctor Anywhere to more than US$104 million.

The latest investment will help the company deepen its presence in its existing markets and expand into new markets.

“We will utilise this funding to enhance our digital capabilities further and scale upon our ability to deliver quality healthcare seamlessly to our users in Southeast Asia,” said Lim Wai Mun, founder and CEO of Doctor Anywhere.

Also Read: How telehealth startup Doctor Anywhere stepped up to the COVID-19 challenge

As per the deal, Asia Partners co-founder Oliver Rippel and Novo’s senior partner Dr Amit Kakar will join the healthtech firm’s Board of Directors.

Launched in 2017, Doctor Anywhere is an omnichannel healthcare company that aims to make healthcare accessible and efficient for everyone. Its digital platform bridges gaps in the healthcare ecosystem through technology and innovation, enabling users to manage their health effectively through its mobile app. 

Currently, Doctor Anywhere serves more than 1.5 million users across Southeast Asia. It has close to 2,800 doctors and medical professionals within its network in the region, and it also works closely with major hospitals and healthcare institutions.

Doctor Anywhere is available in Singapore, Malaysia, Thailand, Vietnam, and the Philippines. The group also recently announced establishing regional tech hubs in Bangalore, India, and Ho Chi Minh City, Vietnam.

In March 2020, Doctor Anywhere secured a US$27 million Series B financing round led by Square Peg. Its Series A round of US4.1 million came in 2018, anchored by Kamet Capital Partners.

“Our mission is to be the largest tech-enabled omnichannel healthcare provider in Southeast Asia, and applying innovative technology to improving patient outcomes is core to our differentiated offerings,” added Lim.

Asia Partners’s Rippel said: “As our region’s leading omnichannel healthcare innovator, DA is helping the healthcare industry rise to the occasion for the challenges and opportunities in the decade ahead. We are proud to be partnering with DA to support its continued growth.”

Image Credit: Doctor Anywhere

The post Doctor Anywhere nets US$65.7 M Series C for geographical expansion appeared first on e27.

content first appear on e27

Leave a Reply

Your email address will not be published.